HIF dysregulation as a novel genetic model to study retinal neovascular disease.
HIF 失调作为研究视网膜新生血管疾病的新型遗传模型。
基本信息
- 批准号:8857468
- 负责人:
- 金额:$ 17.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAge related macular degenerationAreaBiochemicalBlindnessBlood VesselsBlood-Retinal BarrierCell CommunicationCellsClinicalConfocal MicroscopyDevelopmentDiseaseEdemaEtiologyEventEyeEye NeoplasmsFamilyFluorescence Resonance Energy TransferGenesGenetic ModelsGoalsGrowthGrowth FactorHistopathologyHumanHypoxiaHypoxia Inducible FactorImaging TechniquesIschemiaLesionLifeMacular degenerationMentorsModelingMolecularMusNeovascular GlaucomaPathogenesisPathologic NeovascularizationPatientsPhenotypePrincipal InvestigatorProductionProteinsRegulationRelative (related person)ResearchResearch PersonnelRetinaRetinalRetinal Artery OcclusionRetinal DiseasesRetinal NeovascularizationRetinopathy of PrematurityRoleStimulusStructure of central vein of the retinaSyndromeTestingTissuesTrainingTumor Suppressor GenesUp-RegulationVHL proteinVascular Endothelial Growth FactorsVascular PermeabilitiesVon Hippel-Lindau SyndromeWorkangiogenesisbaseexperiencehemangioblastomahypoxia inducible factor 1in vivoin vivo Modelinsightinterestneovascularneovascularizationnoveloverexpressionprogramsproliferative diabetic retinopathyprotein complexskillstranscription factortumor
项目摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to provide the principal investigator (PI) with the experience and skills necessary to become an independent researcher studying basic mechanisms of retinal neovascular disease. The scientific focus of this proposal is to gain a better understanding of pathological angiogenesis in the eye, a principal cause of irreversible blindness worldwide. Emerging evidence suggests a shared etiology for neovascularization in the eye in which local hypoxia leads to upregulation of the hypoxia inducible factor (HIFs). HIFs are a family of transcription factors which stimulate production of several "hypoxia inducible" genes, including angiogenic growth factors (e.g. vascular endothelial growth factor or VEGF), which, in turn, promote the growth of (leaky) blood vessels. Of interest, significant progress in our understanding of the regulation of HIFs in pathological angiogenesis has come from recent work examining the dysregulation of HIFs in patients with von Hippel-Lindau (VHL) disease. Retinal hemangioblastomas are neovascular tumors that remain the most common clinical manifestation in patients with VHL disease, often manifesting with profuse edema and resulting in profound loss of vision. The VHL protein (pVHL) targets HIFs for degradation. Therefore, loss of pVHL in patients with VHL disease results in dysregulation of HIFs and over expression of hypoxia-inducible genes, mimicking pathological angiogenesis. The underlying hypothesis of this proposal is that VHL retinal hemangioblastomas are a model for pathological angiogenesis and provide an ideal genetic model to examine the role(s) of HIFs and their targets in the breakdown of the inner blood- retinal barrier (iBRB), a poorly understood, but critical early event in retinal neovascular disease. To address this hypothesis, three specific aims are proposed: Aim 1: To examine the necessity for HIFs in the breakdown of the iBRB. Aim 2: To determine if HIF dysregulation is sufficient to promote breakdown of the iBRB. Aim 3: To determine the relative contribution of HIF-dependent growth factors in breakdown of the iBRB. In the course of the proposed research and selected didactic activities, the PI will gain invaluable training experience and mentoring in studying the molecular pathogenesis of retinal neovascular disease. This expertise is deemed essential for the PI who aspires to develop an independent research program studying basic mechanisms of retinal pathological angiogenesis.
描述(由申请人提供):本提案的总体目标是为主要研究者(PI)提供必要的经验和技能,使其成为研究视网膜新生血管疾病基本机制的独立研究者。该提案的科学重点是更好地了解眼睛中的病理性血管生成,这是全球不可逆失明的主要原因。新出现的证据表明,局部缺氧导致缺氧诱导因子(HIF)上调的眼部新生血管形成的共同病因。HIF是一个转录因子家族,其刺激几种“缺氧诱导型”基因的产生,包括血管生成生长因子(例如血管内皮生长因子或VEGF),其进而促进(渗漏)血管的生长。有趣的是,我们对HIF在病理性血管生成中的调节的理解的重大进展来自于最近的研究von Hippel-Lindau(VHL)病患者中HIF调节异常的工作。视网膜血管母细胞瘤是新生血管性肿瘤,仍然是VHL疾病患者最常见的临床表现,通常表现为大量水肿并导致严重的视力丧失。VHL蛋白(pVHL)靶向HIF进行降解。因此,VHL疾病患者中pVHL的缺失导致HIF的失调和缺氧诱导基因的过度表达,模拟病理性血管生成。 该提议的基本假设是VHL视网膜成血管细胞瘤是病理性血管生成的模型,并提供了理想的遗传模型来检查HIF及其靶标在内部血-视网膜屏障(iBRB)破坏中的作用,iBRB是视网膜新生血管疾病中理解不多但关键的早期事件。为了解决这一假设,提出了三个具体的目标:目标1:研究在iBRB的故障的HIF的必要性。目的2:确定HIF失调是否足以促进iBRB的破坏。目的3:确定HIF依赖性生长因子在iBRB分解中的相对贡献。 在拟议的研究和选定的教学活动的过程中,PI将获得宝贵的培训经验和指导,在研究视网膜新生血管疾病的分子发病机制。这种专业知识被认为是必不可少的PI谁渴望开发一个独立的研究计划,研究视网膜病理性血管生成的基本机制。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Re: Kwon et al.: Aqueous levels of angiopoietin-like 4 and semaphorin 3E correlate with nonperfusion area and macular volume in diabetic retinopathy (Ophthalmology 2015;122:968-75).
回复:Kwon 等人:血管生成素样 4 和脑信号蛋白 3E 的水浓度与糖尿病视网膜病变的非灌注面积和黄斑体积相关(眼科 2015;122:968-75)。
- DOI:10.1016/j.ophtha.2015.05.023
- 发表时间:2016
- 期刊:
- 影响因子:13.7
- 作者:Sodhi,Akrit;Montaner,Silvia
- 通讯作者:Montaner,Silvia
Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
缺氧通过增强的Notch和MAPK激活促进紫veal黑色素瘤的侵袭。
- DOI:10.1371/journal.pone.0105372
- 发表时间:2014
- 期刊:
- 影响因子:3.7
- 作者:Asnaghi L;Lin MH;Lim KS;Lim KJ;Tripathy A;Wendeborn M;Merbs SL;Handa JT;Sodhi A;Bar EE;Eberhart CG
- 通讯作者:Eberhart CG
Angiopoietin-like 4 as an Emerging Therapeutic Target for Diabetic Eye Disease.
血管生成素样 4 作为糖尿病眼病的新兴治疗靶点。
- DOI:10.1001/jamaophthalmol.2015.3723
- 发表时间:2015
- 期刊:
- 影响因子:8.1
- 作者:Sodhi,Akrit;Montaner,Silvia
- 通讯作者:Montaner,Silvia
Scleral penetration of an unusually aggressive case of a retinal hemangioblastoma.
异常侵袭性视网膜血管母细胞瘤病例的巩膜穿透。
- DOI:10.1016/j.jcjo.2013.01.014
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Rodrigues,Murilo;Iliff,NicholasT;Eberhart,CharlesG;Montaner,Silvia;Sodhi,Akrit
- 通讯作者:Sodhi,Akrit
Intraoperative optical coherence tomography demonstrates immediate closure of a traumatic macular hole.
术中光学相干断层扫描显示外伤性黄斑裂孔立即闭合。
- DOI:10.1016/j.jcjo.2015.12.018
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:He,Lingmin;Sodhi,Akrit
- 通讯作者:Sodhi,Akrit
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Akrit Singh Sodhi其他文献
Akrit Singh Sodhi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Akrit Singh Sodhi', 18)}}的其他基金
Molecular Engineering of Novel Therapies to Treat Corneal Neovascularization
治疗角膜新生血管的新疗法的分子工程
- 批准号:
10592879 - 财政年份:2023
- 资助金额:
$ 17.96万 - 项目类别:
Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal Disease
缺氧诱导因子-1 和-2 在缺血性视网膜疾病中的不同作用
- 批准号:
10589944 - 财政年份:2019
- 资助金额:
$ 17.96万 - 项目类别:
Divergent Roles for Hypoxia-Inducible Factor-1 and -2 in Ischemic Retinal Disease
缺氧诱导因子-1 和-2 在缺血性视网膜疾病中的不同作用
- 批准号:
10359204 - 财政年份:2019
- 资助金额:
$ 17.96万 - 项目类别:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
HIF 失调作为研究视网膜新生血管疾病的新型遗传模型。
- 批准号:
8242691 - 财政年份:2011
- 资助金额:
$ 17.96万 - 项目类别:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
HIF 失调作为研究视网膜新生血管疾病的新型遗传模型。
- 批准号:
8650284 - 财政年份:2011
- 资助金额:
$ 17.96万 - 项目类别:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
HIF 失调作为研究视网膜新生血管疾病的新型遗传模型。
- 批准号:
8032771 - 财政年份:2011
- 资助金额:
$ 17.96万 - 项目类别:
HIF dysregulation as a novel genetic model to study retinal neovascular disease.
HIF 失调作为研究视网膜新生血管疾病的新型遗传模型。
- 批准号:
8440784 - 财政年份:2011
- 资助金额:
$ 17.96万 - 项目类别:
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 17.96万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 17.96万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 17.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 17.96万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 17.96万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 17.96万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 17.96万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 17.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 17.96万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 17.96万 - 项目类别: